Engene Holdings Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.91

+0.00 (+0.00%)

As of Sep 20, 10:22 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 10 56%

Hold 7 39%

Sell 1 6%

Price Target

Analyst Price Target +3,320.4% upside

Low Target $48.23

Average Target $65.33

High Target $96.03

Current Price $1.91

Current
$1.91

Target
$65.33

$48.23 $65.33 avg $96.03

Scenario Analysis

Bear Case

$48.23

2,425.1%

Low target

Base Case

$65.33

+3,320.4%

Avg target

Bull Case

$96.03

+4,927.7%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$12.25

-84.4% from high

52-Week Low

$1.40

+36.4% from low

Target vs 52W High

$65.33

+433.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%